CN114958796A - Glycosylation method of curcumin - Google Patents
Glycosylation method of curcumin Download PDFInfo
- Publication number
- CN114958796A CN114958796A CN202210731651.2A CN202210731651A CN114958796A CN 114958796 A CN114958796 A CN 114958796A CN 202210731651 A CN202210731651 A CN 202210731651A CN 114958796 A CN114958796 A CN 114958796A
- Authority
- CN
- China
- Prior art keywords
- ala
- curcumin
- leu
- gly
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 title claims abstract description 76
- 235000012754 curcumin Nutrition 0.000 title claims abstract description 36
- 229940109262 curcumin Drugs 0.000 title claims abstract description 36
- 239000004148 curcumin Substances 0.000 title claims abstract description 36
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 title claims abstract description 36
- 230000013595 glycosylation Effects 0.000 title claims abstract description 21
- 238000006206 glycosylation reaction Methods 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 18
- 108010009751 sucrose-phosphatase Proteins 0.000 claims abstract description 31
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 9
- 101150031572 gtfA gene Proteins 0.000 claims abstract description 9
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract description 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 239000000348 glycosyl donor Substances 0.000 claims description 8
- 125000003147 glycosyl group Chemical group 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 230000002255 enzymatic effect Effects 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 238000006276 transfer reaction Methods 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- ZTOKUMPYMPKCFX-CZNUEWPDSA-N (E)-17-[(2R,3R,4S,5S,6R)-6-(acetyloxymethyl)-3-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxyoctadec-9-enoic acid Chemical group OC(=O)CCCCCCC/C=C/CCCCCCC(C)O[C@@H]1O[C@H](COC(C)=O)[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(C)=O)O1 ZTOKUMPYMPKCFX-CZNUEWPDSA-N 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 2
- 241000235058 Komagataella pastoris Species 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 125000000185 sucrose group Chemical group 0.000 claims description 2
- 230000001279 glycosylating effect Effects 0.000 claims 7
- 238000005516 engineering process Methods 0.000 abstract description 4
- 235000003373 curcuma longa Nutrition 0.000 abstract description 3
- 238000006911 enzymatic reaction Methods 0.000 abstract description 3
- 235000003392 Curcuma domestica Nutrition 0.000 abstract description 2
- 235000013976 turmeric Nutrition 0.000 abstract description 2
- 244000008991 Curcuma longa Species 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 108010061238 threonyl-glycine Proteins 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108010050848 glycylleucine Proteins 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- FFZJHQODAYHGPO-KZVJFYERSA-N Ala-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N FFZJHQODAYHGPO-KZVJFYERSA-N 0.000 description 3
- 244000163122 Curcuma domestica Species 0.000 description 3
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 3
- 108010091086 Recombinases Proteins 0.000 description 3
- 102000018120 Recombinases Human genes 0.000 description 3
- 108010047495 alanylglycine Proteins 0.000 description 3
- 108010087924 alanylproline Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 2
- 101100153581 Bacillus anthracis topX gene Proteins 0.000 description 2
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 2
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 2
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 2
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 2
- DWPXHLIBFQLKLK-CYDGBPFRSA-N Pro-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 DWPXHLIBFQLKLK-CYDGBPFRSA-N 0.000 description 2
- 108020000005 Sucrose phosphorylase Proteins 0.000 description 2
- 101150041570 TOP1 gene Proteins 0.000 description 2
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 2
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 2
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 108010036413 histidylglycine Proteins 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- -1 phospho Chemical class 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000006098 transglycosylation Effects 0.000 description 2
- 238000005918 transglycosylation reaction Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 1
- VWWKKDNCCLAGRM-GVXVVHGQSA-N (2s)-2-[[2-[[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]propanoyl]amino]acetyl]amino]-3-methylbutanoic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O VWWKKDNCCLAGRM-GVXVVHGQSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- DVJSJDDYCYSMFR-ZKWXMUAHSA-N Ala-Ile-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O DVJSJDDYCYSMFR-ZKWXMUAHSA-N 0.000 description 1
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 1
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- XSTZMVAYYCJTNR-DCAQKATOSA-N Ala-Met-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XSTZMVAYYCJTNR-DCAQKATOSA-N 0.000 description 1
- ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 1
- OLVCTPPSXNRGKV-GUBZILKMSA-N Ala-Pro-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OLVCTPPSXNRGKV-GUBZILKMSA-N 0.000 description 1
- YHBDGLZYNIARKJ-GUBZILKMSA-N Ala-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N YHBDGLZYNIARKJ-GUBZILKMSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 1
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 1
- 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 101710205660 Calcium-transporting ATPase Proteins 0.000 description 1
- 101710134161 Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type Proteins 0.000 description 1
- 240000001829 Catharanthus roseus Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- HXXFSFRBOHSIMQ-UHFFFAOYSA-N Di-K salt-alpha-D-Pyranose-Galactose 1-dihydrogen phosphate Natural products OCC1OC(OP(O)(O)=O)C(O)C(O)C1O HXXFSFRBOHSIMQ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 1
- FQKKPCWTZZEDIC-XPUUQOCRSA-N Gly-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 FQKKPCWTZZEDIC-XPUUQOCRSA-N 0.000 description 1
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- DENRBIYENOKSEX-PEXQALLHSA-N Gly-Ile-His Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 DENRBIYENOKSEX-PEXQALLHSA-N 0.000 description 1
- BHPQOIPBLYJNAW-NGZCFLSTSA-N Gly-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN BHPQOIPBLYJNAW-NGZCFLSTSA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 1
- UWQDKRIZSROAKS-FJXKBIBVSA-N Gly-Met-Thr Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UWQDKRIZSROAKS-FJXKBIBVSA-N 0.000 description 1
- NSVOVKWEKGEOQB-LURJTMIESA-N Gly-Pro-Gly Chemical compound NCC(=O)N1CCC[C@H]1C(=O)NCC(O)=O NSVOVKWEKGEOQB-LURJTMIESA-N 0.000 description 1
- ZZWUYQXMIFTIIY-WEDXCCLWSA-N Gly-Thr-Leu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O ZZWUYQXMIFTIIY-WEDXCCLWSA-N 0.000 description 1
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 1
- RYAOJUMWLWUGNW-QMMMGPOBSA-N Gly-Val-Gly Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O RYAOJUMWLWUGNW-QMMMGPOBSA-N 0.000 description 1
- FULZDMOZUZKGQU-ONGXEEELSA-N Gly-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN FULZDMOZUZKGQU-ONGXEEELSA-N 0.000 description 1
- ORERHHPZDDEMSC-VGDYDELISA-N His-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N ORERHHPZDDEMSC-VGDYDELISA-N 0.000 description 1
- NBWATNYAUVSAEQ-ZEILLAHLSA-N His-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)O NBWATNYAUVSAEQ-ZEILLAHLSA-N 0.000 description 1
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 1
- WUEIUSDAECDLQO-NAKRPEOUSA-N Ile-Ala-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)O)N WUEIUSDAECDLQO-NAKRPEOUSA-N 0.000 description 1
- DFFTXLCCDFYRKD-MBLNEYKQSA-N Ile-Gly-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N DFFTXLCCDFYRKD-MBLNEYKQSA-N 0.000 description 1
- PMMMQRVUMVURGJ-XUXIUFHCSA-N Ile-Leu-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O PMMMQRVUMVURGJ-XUXIUFHCSA-N 0.000 description 1
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 1
- KCTIFOCXAIUQQK-QXEWZRGKSA-N Ile-Pro-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O KCTIFOCXAIUQQK-QXEWZRGKSA-N 0.000 description 1
- CNMOKANDJMLAIF-CIQUZCHMSA-N Ile-Thr-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O CNMOKANDJMLAIF-CIQUZCHMSA-N 0.000 description 1
- NURNJECQNNCRBK-FLBSBUHZSA-N Ile-Thr-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NURNJECQNNCRBK-FLBSBUHZSA-N 0.000 description 1
- 241000218492 Lactobacillus crispatus Species 0.000 description 1
- QPRQGENIBFLVEB-BJDJZHNGSA-N Leu-Ala-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QPRQGENIBFLVEB-BJDJZHNGSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- HRTRLSRYZZKPCO-BJDJZHNGSA-N Leu-Ile-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HRTRLSRYZZKPCO-BJDJZHNGSA-N 0.000 description 1
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 1
- QONKWXNJRRNTBV-AVGNSLFASA-N Leu-Pro-Met Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)N QONKWXNJRRNTBV-AVGNSLFASA-N 0.000 description 1
- PWPBLZXWFXJFHE-RHYQMDGZSA-N Leu-Pro-Thr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O PWPBLZXWFXJFHE-RHYQMDGZSA-N 0.000 description 1
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 1
- 241000051663 Marinobacter flavimaris Species 0.000 description 1
- FZUNSVYYPYJYAP-NAKRPEOUSA-N Met-Ile-Ala Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O FZUNSVYYPYJYAP-NAKRPEOUSA-N 0.000 description 1
- QLESZRANMSYLCZ-CYDGBPFRSA-N Met-Pro-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QLESZRANMSYLCZ-CYDGBPFRSA-N 0.000 description 1
- IIHMNTBFPMRJCN-RCWTZXSCSA-N Met-Val-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IIHMNTBFPMRJCN-RCWTZXSCSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000151743 Paenibacillus sp. A3 Species 0.000 description 1
- DZZCICYRSZASNF-FXQIFTODSA-N Pro-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 DZZCICYRSZASNF-FXQIFTODSA-N 0.000 description 1
- CGSOWZUPLOKYOR-AVGNSLFASA-N Pro-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 CGSOWZUPLOKYOR-AVGNSLFASA-N 0.000 description 1
- SBVPYBFMIGDIDX-SRVKXCTJSA-N Pro-Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H]2NCCC2)CCC1 SBVPYBFMIGDIDX-SRVKXCTJSA-N 0.000 description 1
- DCHQYSOGURGJST-FJXKBIBVSA-N Pro-Thr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O DCHQYSOGURGJST-FJXKBIBVSA-N 0.000 description 1
- 241000192031 Ruminococcus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- ZUGXSSFMTXKHJS-ZLUOBGJFSA-N Ser-Ala-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O ZUGXSSFMTXKHJS-ZLUOBGJFSA-N 0.000 description 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 1
- IFPBAGJBHSNYPR-ZKWXMUAHSA-N Ser-Ile-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O IFPBAGJBHSNYPR-ZKWXMUAHSA-N 0.000 description 1
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 1
- VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 description 1
- 108700006291 Sucrose-phosphate synthases Proteins 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- FIFDDJFLNVAVMS-RHYQMDGZSA-N Thr-Leu-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O FIFDDJFLNVAVMS-RHYQMDGZSA-N 0.000 description 1
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 1
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 1
- NHQVWACSJZJCGJ-FLBSBUHZSA-N Thr-Thr-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NHQVWACSJZJCGJ-FLBSBUHZSA-N 0.000 description 1
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 1
- AKHDFZHUPGVFEJ-YEPSODPASA-N Thr-Val-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AKHDFZHUPGVFEJ-YEPSODPASA-N 0.000 description 1
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 1
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 1
- XTDDIVQWDXMRJL-IHRRRGAJSA-N Val-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N XTDDIVQWDXMRJL-IHRRRGAJSA-N 0.000 description 1
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 1
- JVGHIFMSFBZDHH-WPRPVWTQSA-N Val-Met-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)O)N JVGHIFMSFBZDHH-WPRPVWTQSA-N 0.000 description 1
- STIMNHRZMRZOHW-SQOUGZDYSA-N [(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoyl]phosphonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)P(O)(O)=O STIMNHRZMRZOHW-SQOUGZDYSA-N 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001567 anti-fibrinolytic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940000489 arsenate Drugs 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 108010010165 curculin Proteins 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000005858 glycosidation reaction Methods 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010078326 glycyl-glycyl-valine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 239000012052 hydrophilic carrier Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 108010009932 leucyl-alanyl-glycyl-valine Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000002088 nanocapsule Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000001607 nephroprotective effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 108010008005 sugar-phosphatase Proteins 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01007—Sucrose phosphorylase (2.4.1.7)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a glycosylation method of curcumin, belonging to the technical field of biology. The amino acid sequence of the sucrose phosphatase gtfA is shown as a sequence 1. The sucrose phosphatase was cloned into Lactobacillus reuteri. The invention provides a high-efficiency turmeric glycosylation enzymatic reaction technology.
Description
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a curcumin glycosylation method.
Background
Curcumin (curculin) is a natural polyphenol plant compound which can be used as both medicine and food and is extracted from the rhizome of curcuma zedoary and curcuma longa of traditional Chinese medicines. Curcumin is also used in the united states to color pastry, mustard, curry and dairy products as well as rice, meat and fish dishes. In addition to these uses, curcumin also has good pharmacological properties, such as antioxidant, anticancer, anti-inflammatory and anti-fibrinolytic effects. Therefore, it has long been recognized as a potential health-promoting natural compound that can prevent heart disease and has hepatoprotective and nephroprotective activities. Over the past several decades, extensive studies have demonstrated the pharmacological mechanisms of curcumin, such as inhibition of experimental allergic encephalomyelitis to treat multiple central sclerosis, and as a sarcoplasmic/endoplasmic reticulum calcium pump against cystic fibrosis.
However, curcumin has very low water solubility, which results in poor pharmacokinetic/pharmacodynamic (PK/PD) properties, and low bioavailability, which prevents its further use. Therefore, improving the water solubility of curcumin has become an urgent technical problem in economic value. In the prior art, the water content of curcumin can be improved through a nano/microcapsule embedding mode, but the problem of bioavailability cannot be really solved by a dispersion method of a hydrophilic carrier (DOI: 10.1016/j.molstrac.2020.129774).
In the prior art, glycosylation is considered to be an effective means for effectively improving the water solubility and bioavailability of curcumin. Therefore, the efficient and low-cost glycosylation technical means is a key technology for obtaining the glycosylated curcumin. GR Vijayakumar discloses a technical scheme for glycosidation of curcumin by using amyloglucosidase in the prior art, however, the catalytic efficiency of the enzyme is low, and the molar conversion rate (glycosylation rate) of glycosylation can only reach 48 percent at most (DOI: 10.1108/02632770710753307). Y Kaminaga discloses a technical scheme for biocatalysis of curcumin glycosylation by using suspension cells of the roots of the catharanthus roseus, however, the glycosylation rate of curcumin is only 32 percent, and the yield is only 2.5 mu mol/g (DOI: 10.1016/S0014-5793 (03)) 01265-1.
Disclosure of Invention
The invention aims to provide a curcumin glycosylation method. To solve the above-mentioned problems of the prior art.
The purpose of the invention is realized by the following technical scheme.
A sucrose phosphatase gtfA for curcumin glycosylation has an amino acid sequence shown in sequence 1, and is cloned to Lactobacillus reuteri.
A method for glycosylation of curcumin comprises using sucrose phosphatase gtfA as catalyst, and obtaining glycosylated curcumin by enzymatic glycosyl transfer reaction in the presence of glycosyl donor.
Furthermore, the amino acid sequence of the sucrose phosphatase gtfA is shown as a sequence 1.
Furthermore, the sucrose phosphatase can be expressed by recombinant bacteria of expression hosts such as escherichia coli, pichia pastoris, saccharomyces cerevisiae, corynebacterium glutamicum and the like.
Further, the glycosyl donor is one of sucrose, maltose, 1-phosphate-glucose and 6-phosphate-glucose.
Preferably, the glycosyl donor is sucrose or 1-phospho-glucose.
Preferably, the enzymatic glycosyl transfer reaction is carried out under reaction conditions of pH 6.0-7.5 and temperature 35-45 ℃.
Further, the reaction condition of the enzymatic glycosyl transfer reaction is to add a surfactant as a solubilizer.
Preferably, the surfactant is sophorolipid.
Sucrose phosphatase (also known as sucrose: phospho α -D glucosyltransferase; EC 2.4.1.7) catalyzes the reversible conversion of sucrose (α -D-glucopyranosyl-1, 2- β -D-fructofuranoside) and phosphate to α -D-glucopyranosyl-1-phosphate (Glc1P) and D-fructose. The KEGG database indicates that sucrose phosphatase is involved in the breakdown and synthesis of sucrose. Sucrose phosphorylase is known in the art to catalyze three types of reactions between phosphate and glucose groups, including hydrolysis and synthesis of phosphate, and hydrolysis and transglycosylation of sugar groups. Arsenate can replace phosphate as a substrate for the glucose-based acceptor. Sucrose phosphatases have also been reported to be useful for glycosylation of polyphenols, including catechin and (-) -epigallocatechin.
The invention provides a high-efficiency turmeric glycosylation enzymatic reaction technology.
Detailed Description
The technical features of the present invention will be further described with reference to specific embodiments.
Example 1: expression of recombinant sucrose phosphatase A
The sucrose phosphatase A sequence 1) is subjected to codon optimization according to the codon bias of escherichia coli, and the optimized gene sequence is shown as a sequence 2. The sucrose phosphatase is derived from Lactobacillus reuteri (Lactobacillus reuteri) and is artificially optimized. The codon-optimized sucrose phosphatase A gene sequence was synthesized and subcloned into E.coli expression vector pET30a (+) (the gene synthesis and subcloning process was committed to Jinzhi corporation, Suzhou, pET30a (+) is a published commercial E.coli expression vector). The recombinant plasmid pET30a-A carrying the sucrose phosphatase A gene was transformed into the E.coli BL21(DE3) host by the same company, and screened overnight on LB-resistant solid medium containing chloramphenicol (34. mu.g/mL). And selecting single colonies of the positive clones, and respectively selecting the single colonies to shake flasks for expression of the recombinase. The shake flask induction expression of the recombinase adopts LB culture medium (peptone 10g/L, yeast powder 5g/L, sodium chloride 10g/L), the positive clone strain collected by the LB resistance solid culture medium is inoculated into a shake flask, and then cultured at 37 ℃ until the turbidity OD600 is 0.6-1.0, and then the induced recombinant sucrose phosphatase A expression (the final concentration in the shake flask is 0.4mM) of IPTG (isopropyl thiogalactoside) is added, and simultaneously, the temperature is reduced to 25 ℃ for culture for 8-14 h. The activity of sucrose phosphatase A enzyme was detected by using a sucrose phosphate synthase activity detection kit (manufactured by Shanghai Ji to Biochemical technologies, Ltd.) according to the instruction, and the clone top1 having the highest enzyme activity was selected as an expression strain of the recombinase.
The top1 clone was used as an expression strain, and enzyme production was performed in a 10L fermentor. The fermentation tank culture adopts fermentation medium (peptone 10g/L, yeast powder 5g/L, sodium chloride 8g/L, glycerol 10g/L, magnesium sulfate 1g/L, potassium dihydrogen phosphate 1g/L, dipotassium hydrogen phosphate 2g/L), feed is 30% glycerol, and ammonia water is used for controlling pH to be 7.0. After inoculating the fermentation tank, culturing at 37 ℃ for 5h, starting feeding, starting inducing when OD600 is 20, adding IPTG with final concentration of 0.4mM, cooling to 25 ℃, culturing, fermenting for 22h, and discharging. Then, the cells were collected by centrifugation as crude sucrose phosphatase A.
Example 2: expression of sucrose phosphatase A catalyzes curcumin glycosylation
The reaction was carried out using 1. mu.M phosphate buffer as a reaction system containing 30mg/mL of a glycosyl donor, 10mg/mL of the crude sucrose phosphatase gtfA prepared in example 1, 1mg/mL of sophorolipid (Boston Biotech., Ltd.), 0.5mmol/L of curcumin, followed by catalyzing the enzymatic reaction at 37 ℃ for 12 hours with dynamic shaking. The glycosylation donors added in the reaction are shown in table 1.
Before and after the reaction, the content of curcumin and its glycosylated derivatives was measured by HPLC external standard method, the analysis conditions of HPLC were that the column used Cosmosil 5C18-ARII column, 4.6U150mm, Nacalai Tesque, and the mobile phase used the following gradient elution of methanol with water: from 0 to 14 minutes, methanol ratio increased from 40% to 80%; the methanol ratio is increased from 80% to 100% in 14 to 15 minutes, and the isocratic elution with 100% methanol is maintained in 15 to 20 minutes. The flow rate was 1.0 ml/min. The elution was monitored at 423nm on a DAD detector. The amount of product was calculated based on the calibration curve prepared using each curcuminoside.
TABLE 1 glycosylated curcumin product content after different glycosyl donor reactions
Example 3: transglycosylation of other sucrose phosphatases
Sucrose phosphatases from other strains were expressed according to the procedure of example 1, including those from the strain Ruminococcus calillidus, AmyAc sucrose phosphatase (NCBI Reference Sequence: WP-022410484.1), gtfA sucrose phosphatase from the strain Lactobacillus crispatus (NCBI Reference Sequence: WP-060461996.1), sucrose phosphatase from Paenibacillus sp.A3 (NCBI Reference Sequence: WP-054973973.1), and sucrose phosphatase from Marinobacter flavimaris (NCBI Reference Sequence: WP-104270647.1). The gene sequences and amino acid sequences of all enzymes can be queried and obtained publicly from the NCBI database (https:// www.ncbi.nlm.nih.gov /) by means of the NCBI Reference Sequence number. Then, the sucrose phosphatase recombinant enzymes from different sources are subjected to the glycosyl transfer test of Curcumin according to the method described in the embodiment example 2, however, the production of Curcumin 4 '-O-glucoside or Curcumin 4' 4-O-diglucoside or other glycosyl Curcumin is not detected by all 4 recombinant enzymes, so that the sugar phosphatases from the 4 other strains do not have the glycosyl transfer capability of Curcumin as a receptor.
Sequence listing
<110> Shanghai dragon Yin Biotech Co., Ltd
<120> a method for glycosylation of curcumin
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 485
<212> PRT
<213> Lactobacillus reuteri (Lactobacillus reuteri)
<400> 1
Met Pro Ile Leu Ala Gly Ala Met Leu Ile Thr Thr Ser Ala Ser Met
1 5 10 15
Gly Leu Ala Ile Leu Gly Thr His Gly Val Leu Leu Ala Thr Ile Gly
20 25 30
Ala Ala Ile Gly Gly Val His Leu Leu Pro Pro Pro Pro Ser Thr Gly
35 40 45
Ala Ala Gly Pro Ala Pro Thr Ala Thr Ala Val Val Ala Ser Ala Pro
50 55 60
Gly Ala Thr Ala Ala Val Gly Ala Leu Gly Gly Ala Thr Thr Leu Met
65 70 75 80
Pro Ala Pro Met Ile Ala His Ile Ser Leu Leu Ser Gly Met Thr Gly
85 90 95
Ala Pro Leu Leu Leu His Ala Ala Ser Leu Thr Ala Ala Pro Pro Ile
100 105 110
Ala Thr Gly Leu Pro Thr Gly Leu Ala Gly Leu Ala Ala Pro Thr Gly
115 120 125
Gly Ala Val Ala Leu Ile Thr Leu Ala Leu Ala Leu Ala Pro Leu Gly
130 135 140
Gly Ile Thr Pro Ala Ala Gly Thr Thr Gly Ala Leu Thr Ala Thr Pro
145 150 155 160
Gly Gly Gly Gly Ile Ala Ile Ala Val Leu Ser Leu Val Ala Ala Gly
165 170 175
Pro Pro Leu Gly Thr Leu Ile Ala Met Val Leu His Gly Ala Ala Met
180 185 190
Ile Ala Leu Ala Ala Pro Ala Thr Ala Ile Leu Leu Val Gly Thr Ala
195 200 205
Ala Pro Pro Val Gly Pro Gly Ile Thr Ala Leu Leu Ala Gly Val Gly
210 215 220
Ala Ile Leu Ala Pro Thr Leu Ala Ile Ile Leu Pro Gly Ile His Gly
225 230 235 240
His Thr Thr Ile Pro Gly Leu Ile Ser Gly His Ala Pro Pro Ile Thr
245 250 255
Ala Pro Thr Leu Pro Met Thr Thr Leu Thr Thr Leu Thr Ser Gly Leu
260 265 270
Thr Ala Ala Leu Ala Leu Thr Leu Leu Met Ser Pro Met Leu Gly Pro
275 280 285
Thr Thr Leu Ala Thr His Ala Gly Ile Gly Val Val Ala Ala Leu Ala
290 295 300
Ile Leu Thr Ala Ala Gly Ile Gly Thr Ala Ser Ala Gly Leu Thr Leu
305 310 315 320
Val Gly Ala Ala Val Leu Ala Leu Thr Ser Ser Ala Gly Thr Ala Ala
325 330 335
Leu Ala Ile Thr Gly Ile Ala Ser Thr Thr Thr Ser Ala Leu Gly Ala
340 345 350
Ala Ala Leu Ala Thr Leu Leu Ser Ala Ala Pro Gly Val Pro Ala Pro
355 360 365
Gly Ile Pro Met Val Thr Thr Val Gly Leu Leu Ala Gly Ser Ala Ala
370 375 380
Leu Gly Leu Leu Gly Leu Thr Leu Gly Gly Ala Ala Ile Ala Ala His
385 390 395 400
Thr Thr Thr Leu Gly Gly Val Ala Gly Gly Val Gly Ala Pro Val Val
405 410 415
Leu Ala Leu Leu Ala Leu Leu Ala Thr Ala Ala Leu Pro Ala Ala Pro
420 425 430
Ala Leu Ala Gly Ser Ile Gly Val Leu Thr Pro Thr Gly Thr Thr Ile
435 440 445
Leu Val Thr Ala Leu Ala Leu Ala Gly Leu Ala Val Ala Val Leu Ala
450 455 460
Ala Ala Ala Ala Ala Leu Thr Pro Thr Ile Thr Ala Ala Gly Gly Leu
465 470 475 480
Val Met Gly Gly Leu
485
<210> 2
<211> 1455
<212> DNA
<213> Lactobacillus reuteri (Lactobacillus reuteri)
<400> 2
atgccgatca aaaacgaagc catgctgatt acgtacagcg attctatggg taaaaacatc 60
aaagaaactc atgaagtgct gaagaactac atcggtgatg cgattggtgg tgtgcacctg 120
ctgccgttct tcccgtctac cggtgaccgt ggcttcgcac cgtatcgtta cgacgttgtt 180
gacagcgcct tcggcaactg ggatgatgtt gaagctctgg gtgaagatta ctacctgatg 240
ttcgacttca tgatcaacca catctctaaa aaaagcgaaa tgtatcagga ttttaagaaa 300
aaacacgatg actctaaata taacgatttc ttcattcgtt gggaaaaatt ttgggaaaaa 360
gccggcaaaa accgcccgac ccaggaagac gtagacctga tctataaacg caaagacaaa 420
gccccgaaac aggaaatcac cttcgatgat ggtactacgg aaaacctgtg gaacactttc 480
ggtgaagaac agattgatat taacgttaag tccaaagtag cgaacgaatt ttttaaagaa 540
acgctgattg atatggttaa acacggtgct gatatgatcc gtctggatgc cttcgcgtat 600
gctattaaaa aagtcggcac caacgacttc tttgttgaac ctgaaatctg ggacctgctg 660
aacgaggttc aagacatcct ggcaccgtac aaagcaatca tcctgccgga gatccacgaa 720
cactacacta ttccgcagaa aatcagccag cacgatttct tcatctacga ttttaccctg 780
cctatgacca ccctgtacac tctgtacagc ggtaaaacca accgcctggc taaatggctg 840
aaaatgtctc cgatgaaaca gtttaccact ctggataccc acgacggcat cggtgtggtt 900
gatgcgaagg acattctgac cgacgacgaa atcgaatacg cttctaacga gctgtataaa 960
gttggtgcca atgtgaaacg taaatattcc tctgctgaat acaacaacct ggacatctac 1020
cagattaact ctacctacta ctctgctctg ggcgatgacg ataaagcata tctgctgtcc 1080
cgtgcattcc aggtgttcgc accgggtatt ccgatggttt actacgtagg tctgctggct 1140
ggttctaacg acctggagct gctggaaaaa accaaagagg gccgtaacat caaccgtcac 1200
tattacacca aagaagaagt tgcgcaagag gttcaacgcc cggtggtcaa aaacctgctg 1260
gatctgctgg cgtggcgtaa caaattcgcc gcctttgatc tggatggctc tatcgaagtg 1320
aagactccga ccgaaactac tattaaagtc acccgtaaag acaaggatgg taaaaacgtc 1380
gcggtgctgg atgctgatgc ggccaacaaa acgttcacta tcaccgcgaa tggcgagaaa 1440
gttatggaac agaaa 1455
Claims (9)
1. A sucrose phosphatase gtfA useful for curcumin glycosylation characterized by: the amino acid sequence is shown in sequence 1.
2. The sucrose phosphatase gtfA useful for curcumin glycosylation according to claim 1, characterized in that: the sucrose phosphatase was cloned into Lactobacillus reuteri.
3. A method of glycosylating curcumin, characterized by: using sucrose phosphatase gtfA as catalyst, and obtaining glycosylated curcumin by enzymatic glycosyl transfer reaction in the presence of glycosyl donor.
4. A method of glycosylating curcumin as claimed in claim 3, wherein: the sucrose phosphatase can be a recombinant bacterium expressed by an expression host of escherichia coli, pichia pastoris, saccharomyces cerevisiae and corynebacterium glutamicum.
5. A method of glycosylating curcumin as claimed in claim 3, wherein: the glycosyl donor is one of sucrose, maltose, 1-phosphate-glucose and 6-phosphate-glucose.
6. A method of glycosylating curcumin as claimed in claim 5, wherein: the glycosyl donor is sucrose or 1-phosphate-glucose.
7. A method of glycosylating curcumin as claimed in claim 3, wherein: the reaction conditions of the enzymatic glycosyl transfer reaction are that the reaction pH is 6.0-7.5 and the temperature is 35-45 ℃.
8. A method of glycosylating curcumin as claimed in claim 3, wherein: the reaction condition of the enzymatic glycosyl transfer reaction is to add a surfactant as a solubilizer.
9. The method of glycosylating curcumin of claim 8, wherein: the surfactant is sophorolipid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210731651.2A CN114958796A (en) | 2022-06-26 | 2022-06-26 | Glycosylation method of curcumin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210731651.2A CN114958796A (en) | 2022-06-26 | 2022-06-26 | Glycosylation method of curcumin |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114958796A true CN114958796A (en) | 2022-08-30 |
Family
ID=82965151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210731651.2A Pending CN114958796A (en) | 2022-06-26 | 2022-06-26 | Glycosylation method of curcumin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114958796A (en) |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998059108A2 (en) * | 1997-06-20 | 1998-12-30 | Blume, Hildegard | Oxidation and bleaching system with enzymatically produced oxidizing agents |
JP2005312325A (en) * | 2004-04-27 | 2005-11-10 | Sanei Gen Ffi Inc | New glycosyltransferase, and production of curcumin glycoside using the same |
JP2007330112A (en) * | 2006-06-12 | 2007-12-27 | Sanei Gen Ffi Inc | Method for producing glucose glycoside of phenolic compound |
WO2011016260A1 (en) * | 2009-08-07 | 2011-02-10 | 国立大学法人東京農工大学 | Novel glycosyltransferase, novel glycosyltransferase gene, and novel glycosyl donor compound |
CN109750071A (en) * | 2019-01-31 | 2019-05-14 | 南京工业大学 | A kind of method of biocatalysis synthesis Rebaudiodside A M |
CN110156855A (en) * | 2019-05-23 | 2019-08-23 | 广东金骏康生物技术有限公司 | Glycosylated flavanoid and its preparation method and application |
CN111172127A (en) * | 2020-01-17 | 2020-05-19 | 浙江工业大学 | Application of sucrose phosphorylase in preparation of glycerol glucoside |
CN111690624A (en) * | 2020-06-04 | 2020-09-22 | 江南大学 | Method for synthesizing 2-O-alpha-D-glycerol glucoside by using microorganisms |
CN113322219A (en) * | 2021-02-19 | 2021-08-31 | 南京工业大学 | Method for synthesizing curcumin glucoside compound by biological method catalysis |
WO2022127039A1 (en) * | 2020-12-15 | 2022-06-23 | 通辽梅花生物科技有限公司 | Riboflavin-producing bacillus subtilis, and construction method therefor and use thereof |
CN114790472A (en) * | 2022-03-25 | 2022-07-26 | 上海龙殷生物科技有限公司 | Fructose glycosylated curcumin, preparation method and application |
CN115404226A (en) * | 2021-05-27 | 2022-11-29 | 南京工业大学 | Sucrose synthase and application thereof in catalytic glycosylation reaction |
-
2022
- 2022-06-26 CN CN202210731651.2A patent/CN114958796A/en active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998059108A2 (en) * | 1997-06-20 | 1998-12-30 | Blume, Hildegard | Oxidation and bleaching system with enzymatically produced oxidizing agents |
JP2005312325A (en) * | 2004-04-27 | 2005-11-10 | Sanei Gen Ffi Inc | New glycosyltransferase, and production of curcumin glycoside using the same |
JP2007330112A (en) * | 2006-06-12 | 2007-12-27 | Sanei Gen Ffi Inc | Method for producing glucose glycoside of phenolic compound |
WO2011016260A1 (en) * | 2009-08-07 | 2011-02-10 | 国立大学法人東京農工大学 | Novel glycosyltransferase, novel glycosyltransferase gene, and novel glycosyl donor compound |
CN109750071A (en) * | 2019-01-31 | 2019-05-14 | 南京工业大学 | A kind of method of biocatalysis synthesis Rebaudiodside A M |
CN110156855A (en) * | 2019-05-23 | 2019-08-23 | 广东金骏康生物技术有限公司 | Glycosylated flavanoid and its preparation method and application |
CN111172127A (en) * | 2020-01-17 | 2020-05-19 | 浙江工业大学 | Application of sucrose phosphorylase in preparation of glycerol glucoside |
CN111690624A (en) * | 2020-06-04 | 2020-09-22 | 江南大学 | Method for synthesizing 2-O-alpha-D-glycerol glucoside by using microorganisms |
WO2022127039A1 (en) * | 2020-12-15 | 2022-06-23 | 通辽梅花生物科技有限公司 | Riboflavin-producing bacillus subtilis, and construction method therefor and use thereof |
CN113322219A (en) * | 2021-02-19 | 2021-08-31 | 南京工业大学 | Method for synthesizing curcumin glucoside compound by biological method catalysis |
CN115404226A (en) * | 2021-05-27 | 2022-11-29 | 南京工业大学 | Sucrose synthase and application thereof in catalytic glycosylation reaction |
CN114790472A (en) * | 2022-03-25 | 2022-07-26 | 上海龙殷生物科技有限公司 | Fructose glycosylated curcumin, preparation method and application |
Non-Patent Citations (3)
Title |
---|
GENBANK: "NCBI Reference Sequence: WP_152702385.1", GENBANK, pages 1 - 2 * |
RIT BAHADUR GURUNG 等: "Synthesis of Curcumin Glycosides with Enhanced Anticancer Properties Using One-Pot Multienzyme Glycosylation Technique", J MICROBIOL BIOTECHNOL, vol. 27, no. 9, pages 1639 - 1648 * |
冯生光等: "姜黄素降解产物的分离鉴定及姜黄素的稳定性考察", 沈阳药科大学学报, vol. 26, no. 5, pages 361 - 365 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2902410B1 (en) | Method for producing stevioside compounds by microorganism | |
CN108913641B (en) | Recombinant escherichia coli and application thereof | |
CN114350727B (en) | Method for synthesizing D-psicose by combining phosphorylation and ATP regeneration system | |
CN111394292B (en) | Multi-way composite neuraminic acid-producing bacillus subtilis and application thereof | |
CN112708567B (en) | Fructosyltransferase and high-yield strain thereof | |
CN113717910B (en) | Tri-enzyme co-expression recombinant bacterium and application thereof in (S) -citronellol synthesis | |
CN113512505B (en) | Method for preparing erythritol | |
CN109652481A (en) | A kind of application of cyclodextrin glycosyl transferases in production alpha-glycosyl aurantiamarin | |
KR20000076602A (en) | Process for producing purine nucleotides | |
CN111411066B (en) | Double-way composite neuraminic acid-producing bacillus subtilis and construction method thereof | |
CN111394410B (en) | High-catalytic-activity neuraminic acid synthase and application thereof | |
CN114958796A (en) | Glycosylation method of curcumin | |
CN110892068B (en) | UDP-glycosyltransferase | |
CN116355820A (en) | Engineering strain for high yield of ergothioneine and method for producing ergothioneine by same | |
CN113699087B (en) | Lactobacillus plantarum engineering strain for converting lactose to generate lactulose, construction method and application thereof | |
CN114806991A (en) | Engineering escherichia coli for improving yield of fucosyllactose and production method | |
CN110004099A (en) | A kind of fermentation method for producing of rhodioside | |
KR102335035B1 (en) | Process for preparing crocin-4 using enzyme reaction | |
WO2020258896A1 (en) | Strain and method for producing rosmarinic acid | |
CN112111536A (en) | Method for producing spermidine by taking amino acid as substrate and engineering bacteria | |
CN112301011A (en) | Glycosyltransferase variants and uses thereof | |
CN111411065B (en) | Recombinant bacterium for producing N-acetylneuraminic acid based on artificial double carbon sources | |
CN114395542B (en) | Sucrose phosphorylase and application thereof | |
CN114250207B (en) | High-activity sucrose phosphorylase and application thereof | |
CN116445563A (en) | Method for synthesizing D-psicose equilibrium conversion rate by taking sucrose as substrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |